➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Merck
Express Scripts
McKinsey
Dow

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Gliolan


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Gliolan?

Gliolan is an investigational drug.

There have been 16 clinical trials for Gliolan. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.

The most common disease conditions in clinical trials are Glioblastoma, Brain Neoplasms, and Glioma. The leading clinical trial sponsors are Constantinos Hadjipanayis, National Cancer Institute (NCI), and University Hospital, Lille.

Recent Clinical Trials for Gliolan
TitleSponsorPhase
Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain Tumorsmedac GmbHPhase 2
Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain Tumorsphotonamic GmbH & Co. KGPhase 2
Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain TumorsWestfälische Wilhelms-Universität MünsterPhase 2

See all Gliolan clinical trials

Clinical Trial Summary for Gliolan

Top disease conditions for Gliolan
Top clinical trial sponsors for Gliolan

See all Gliolan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Colorcon
Merck
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.